Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$10.64BAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Lukas Jean-Baptiste Paravicini
- Sector
- Consumer Defensive
- Industry
- Tobacco
- Employees
- 25,300
- Beta
- 0.14
- Country
- GB
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 1.29
Financials
Revenue
$10.64B+21.3%Net Income
$1.43B+233.4%EBITDA
$2.19B+3715.6%Free Cash Flow
$3.21B+919.5%EPS (diluted)
$1.83+238.9%Shares Outstanding (diluted)
782.16M-51.5%Operating Expenses
$2.09BCash & Debt
$1.89BReturn of Capital
$1.38BDividend per Share
$0.55Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $20.00B | $1.93B | $2.47 |
| 2025 | $32.17B | $2.07B | $2.51 |
| 2024 | $32.41B | $2.61B | $3.01 |
| 2023 | $32.48B | $2.33B | $2.52 |
| 2022 | $32.55B | $1.57B | $1.66 |
| 2021 | $32.79B | $2.83B | $3.00 |
| 2020 | $32.56B | $1.50B | $1.58 |
| 2019 | $31.59B | $1.01B | $1.06 |
| 2018 | $30.07B | $1.37B | $1.44 |
| 2017 | $30.25B | $1.41B | $1.48 |
| 2016 | $27.63B | $631.00M | $0.66 |
| 2015 | $25.29B | $1.69B | $1.77 |
| 2014 | $26.46B | $1.42B | $1.49 |
| 2013 | $28.27B | $905.00M | $0.96 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from IMBBY's reported EPS growth of 7.5% a year over 13 years.
- EPS in 5 years
- $3.55
- Implied price
- $35.47
- Return from $36.30
- -0.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $17.63 — -51.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| -2.5% | -18.5% | -13.7% | -9.7% | -6.4% | -3.4% |
| 2.5% | -14.3% | -9.2% | -5.1% | -1.6% | 1.5% |
| 7.5% | -10.1% | -4.8% | -0.5% | 3.2% | 6.5% |
| 12.5% | -5.9% | -0.4% | 4.2% | 8.0% | 11.4% |
| 17.5% | -1.8% | 4.0% | 8.8% | 12.8% | 16.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
60+20.00%Social Signal Score
Mentions (5)
- Newsseekingalpha.com·4d ago·Positive
Imperial Brands: Another Solid But Unspectacular Year Imperial Brands remains a hold: after a 22% rally, valuation looks fair, not attractive, given cigarette declines and industry risks. IMBBY's 5.1% price increases offset a 3% tobacco volume decline, though pricing power will eventually reach its limits. The dividend rose 4%, with £1.3bn in payments covered by £2.6bn of free cash flow; £1.6bn of buybacks could be reduced.
View source ↗ - Newsmarketbeat.com·5d ago·Neutral
Imperial Brands H2 Earnings Call Highlights Imperial Brands LON: IMB reported a sixth consecutive year of growth in tobacco and next-generation product revenue and adjusted operating profit, as higher cigarette prices offset falling volumes and its newer nicotine products gained market share.
View source ↗ - Newswsj.com·5d ago·Positive
Imperial Brands Revenue Falls as Tobacco Volumes Slide The company reported a drop in revenue for its full fiscal year, as tobacco volumes declined, but said it outperformed the wider industry in tobacco volumes overall.
View source ↗ - Newsreuters.com·5d ago·Neutral
UK's Imperial Brands to cut up to 2,500 roles by end of 2030 UK's Imperial Brands to cut up to 2,500 roles by end of 2030
View source ↗ - Newsseekingalpha.com·7d ago·Neutral
Imperial Brands: Massive Cash Flow Driving Double-Digit Returns Imperial Brands offers robust cash flows, aggressive buybacks, and a 5.6% dividend yield poised for continued growth. IMBBY has established a pattern of annual dividend increases each May, with the next two dividends expected to be declared at the same level on November 17. Despite Quant concerns about dividend risk, I see the payout as secure, underpinned by a low payout ratio and stable earnings growth.
View source ↗
Earnings
Tue, May 18(in 6 months)
Consensus estimate $1.79 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Nov 17$2.83 vs $2.59beat
- Tue, May 12$1.72 vs $1.72beat
- Tue, Nov 18$2.49 vs $2.55miss
- Wed, May 14$1.65 vs $1.60beat
- Tue, Nov 19$2.22 vs $2.27miss
- Wed, May 15$1.20 vs $1.15beat
Estimates and results for IMBBY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Dec 2, 2020 (19d later)Buy$15,001 - $50,000
- John Henry Rutherfordhouse · FL04 · disclosed May 1, 2020 (16d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Apr 7, 2020 (20d later)Buy$1,001 - $15,000
- Mikie Sherrillhouse · NJ11 · disclosed Jul 8, 2019 (41d later)Sell$1,001 - $15,000
- Greg Gianfortehouse · MT00 · disclosed Jan 23, 2019 (33d later)Sell$15,001 - $50,000
- John Henry Rutherfordhouse · FL04 · disclosed Aug 20, 2018 (111d later)Buy$1,001 - $15,000
- John Henry Rutherfordhouse · FL04 · disclosed Aug 20, 2018 (405d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
